Meeting abstract

https://doi.org/10.15836/ccar2019.210

Reducing the number of days taken for coronary artery bypass grafting for cardiology in-patients within New Cross Hospital, Wolverhampton – a quality improvement project

Sam Hughes orcid.org/0000-0002-3655-131X ; New Cross Hospital [Royal Wolverhampton Trust], Department of Cardiology, Wolverhampton, United Kingdom
Camilla Baker ; New Cross Hospital [Royal Wolverhampton Trust], Department of Cardiology, Wolverhampton, United Kingdom
Abhirami Gautham ; New Cross Hospital [Royal Wolverhampton Trust], Department of Cardiology, Wolverhampton, United Kingdom

Abstract

Background: Following an acute coronary event, the current process of referring a patient for Coronary Artery Bypass Grafting (CABG) at New Cross Hospital, Wolverhampton, has the potential to be improved. At present, patients can wait up to 5 days before being referred to cardiothoracics, often becoming more unwell during the delay. At times, patients become too unwell to undergo the planned surgery. Moreover, additional delays frequently arise due to difficulty tracking the referral.
Objective: To reduce the number of days between coronary angiogram to cardiothoracic review from 3 to 1 AND the number of days between coronary angiogram to CABG from 6 to 5.
Method: The following 2 measures / PDSA cycles were implemented; - Cycle 1: Same-Day Referrals - Upon reviewing the coronary angiogram, if the consultant cardiologist on-call deems the patient to be a ‘clear surgical candidate’, then a ‘same day’ referral to cardiothoracics for pre-assessment via the Teliologic system is made. - Cycle 2: ‘Post-
Angiogram’ Assessment Page [Green Form] - Instead of utilizing numerous non-specific continuation sheets, a dedicated
pro-forma is used to document the coronary angiogram results and to track the patient’s subsequent plan (Figure 1).
Results: Coronary angiogram to cardiothoracic review reduced from 3 to 2 days, whilst from coronary angiogram to CABG reduced from 6 to 5 days. In addition, the average total length of stay has reduced
by 3 days, improving patient outcomes and saving the hospital an average of £1200 per patient.
Discussion and Conclusion: At present, the decision on when anti-platelets [Ticagrelor in particular] should be stopped prior to surgery, varies from 2 days to 7 days, depending on both the patient’s
presentation & the personal preference of each surgeon.1 This is the focus of Cycle 3, namely to implement local trust guidelines
on stopping anti-platelets prior to CABG. Simple improvements in communication have significantly increased the efficiency of this
referral process. For example, in cycle 2 we created a single, unified pro-forma which could be easily identified & updated by each member of the team, improving consistency, continuity of care & avoiding
potential delays for surgery due to mis-placed documentation. In turn, this has reduced patient morbidity & made significant cost savings.

Keywords

cardiology; coronary artery bypass grafting; quality improvement project; surgery

Hrčak ID:

226684

URI

https://hrcak.srce.hr/226684

Publication date:

15.10.2019.

Visits: 711 *